Circulation Research. 2005;97:380-390
Published online before print July 21, 2005,
doi: 10.1161/01.RES.0000178789.16929.cf
(Circulation Research. 2005;97:380.)
© 2005 American Heart Association, Inc.
Combination of Tumor Necrosis Factor-
Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice
Zamaneh Kassiri,
Gavin Y. Oudit,
Otto Sanchez,
Fayez Dawood,
Fazilat F. Mohammed,
Robert K. Nuttall,
Dylan R. Edwards,
Peter P. Liu,
Peter H. Backx,
Rama Khokha
From the Ontario Cancer Institute (Z.K., O.S., F.F.M., R.K.), University of Toronto, University Health Network, Canada; Heart and Stroke/Richard Lewar Center of Excellence (G.Y.O., F.D., P.P.L., P.H.B.), University of Toronto, Ontario, Canada; and the School of Biological Sciences (R.K.N., D.R.E.), University of East Anglia, Norwich, Norfolk, United Kingdom.
Correspondence to Rama Khokha, Ontario Cancer Institute, University of Toronto, 610 University Ave, 10–330, Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada. E-mail rkhokha{at}uhnres.utoronto.ca
Cytokine and extracellular matrix (ECM) homeostasis are distinct systems that are each dysregulated in heart failure. Here we show that tissue inhibitor of metalloproteinase (TIMP)-3 is a critical regulator of both systems in a mouse model of left ventricular (LV) dilation and dysfunction. Timp-3–/– mice develop precipitous LV dilation and dysfunction reminiscent of dilated cardiomyopathy (DCM), culminating in early onset of heart failure by 6 weeks, compared with wild-type aortic-banding (AB). Timp-3 deficiency resulted in increased TNF
converting enzyme (TACE) activity within 6 hours after AB leading to enhanced tumor necrosis factor- (TNF) processing. In addition, TNF production increased in timp-3–/–-AB myocardium. A significant elevation in gelatinase and collagenase activities was observed 1 week after AB, with localized ECM degradation in timp-3–/–-AB myocardium. Timp-3–/–/tnf–/– mice were generated and subjected to AB for comparative analyses with timp-3–/–-AB mice. This revealed the critical role of TNF in the early phase of LV remodeling, de novo expression of Matrix metalloproteinases (MMP)-8 in the absence of TNF, and highlighted the importance of interstitial collagenases (MMP-2, MMP-13, and MT1-MMP) for cardiac ECM degradation. Ablation of TNF, or limiting MMP activity with a synthetic MMP inhibitor (PD166793), each partially attenuated LV dilation and cardiac dysfunction in timp-3–/–-AB mice. Notably, combining TNF ablation with MMP inhibition completely rescued heart disease in timp-3–/–-AB mice. This study provides a basis for anti-TNF and MMP inhibitor combination therapy in heart disease.
Key Words: left ventricular dilation and dysfunction • extracellular matrix • tissue inhibitor of metalloproteinase-3 • matrix metalloproteinase • tumor necrosis factor-
This article has been cited by other articles:
|
|
|
|
 
Z. Kassiri, V. Defamie, M. Hariri, G. Y. Oudit, S. Anthwal, F. Dawood, P. Liu, and R. Khokha
Simultaneous Transforming Growth Factor {beta}-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart
J. Biol. Chem.,
October 23, 2009;
284(43):
29893 - 29904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Kassiri, J. Zhong, D. Guo, R. Basu, X. Wang, P. P. Liu, J. W. Scholey, J. M. Penninger, and G. Y. Oudit
Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
Circ Heart Fail,
September 1, 2009;
2(5):
446 - 455.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, T. Oka, F. L. Chow, S. B. Cooper, J. Odenbach, G. D. Lopaschuk, Z. Kassiri, and C. Fernandez-Patron
Tumor Necrosis Factor-{alpha}-Converting Enzyme Is a Key Regulator of Agonist-Induced Cardiac Hypertrophy and Fibrosis
Hypertension,
September 1, 2009;
54(3):
575 - 582.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Kassiri, G. Y. Oudit, V. Kandalam, A. Awad, X. Wang, X. Ziou, N. Maeda, A. M. Herzenberg, and J. W. Scholey
Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis
J. Am. Soc. Nephrol.,
June 1, 2009;
20(6):
1223 - 1235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Johnson, G. B. Sala-Newby, Y. Ismail, C. M. Aguilera, and A. C. Newby
Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages
Arterioscler Thromb Vasc Biol,
September 1, 2008;
28(9):
1647 - 1653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Y. Oudit, Z. Kassiri, J. Zhou, Q. C. Liu, P. P. Liu, P. H. Backx, F. Dawood, M. A. Crackower, J. W. Scholey, and J. M. Penninger
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress
Cardiovasc Res,
June 1, 2008;
78(3):
505 - 514.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev,
October 1, 2007;
87(4):
1285 - 1342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kuba, L. Zhang, Y. Imai, S. Arab, M. Chen, Y. Maekawa, M. Leschnik, A. Leibbrandt, M. Markovic, J. Schwaighofer, et al.
Impaired Heart Contractility in Apelin Gene Deficient Mice Associated With Aging and Pressure Overload
Circ. Res.,
August 17, 2007;
101(4):
e32 - e42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Wong, G. Y. Oudit, H. Reich, Z. Kassiri, J. Zhou, Q. C. Liu, P. H. Backx, J. M. Penninger, A. M. Herzenberg, and J. W. Scholey
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Am. J. Pathol.,
August 1, 2007;
171(2):
438 - 451.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Y. Oudit, Z. Kassiri, M. P. Patel, M. Chappell, J. Butany, P. H. Backx, R. G. Tsushima, J. W. Scholey, R. Khokha, and J. M. Penninger
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice
Cardiovasc Res,
July 1, 2007;
75(1):
29 - 39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Martino, N. Tata, D. D. Belsham, J. Chalmers, M. Straume, P. Lee, H. Pribiag, N. Khaper, P. P. Liu, F. Dawood, et al.
Disturbed Diurnal Rhythm Alters Gene Expression and Exacerbates Cardiovascular Disease With Rescue by Resynchronization
Hypertension,
May 1, 2007;
49(5):
1104 - 1113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sun, M. Chen, F. Dawood, U. Zurawska, J. Y. Li, T. Parker, Z. Kassiri, L. A. Kirshenbaum, M. Arnold, R. Khokha, et al.
Tumor Necrosis Factor-{alpha} Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State
Circulation,
March 20, 2007;
115(11):
1398 - 1407.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. V. Hojilla, I. Kim, Z. Kassiri, J. E. Fata, H. Fang, and R. Khokha
Metalloproteinase axes increase beta-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3
J. Cell Sci.,
March 15, 2007;
120(6):
1050 - 1060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Gao, J. Xiao, Q. Sun, H. Lin, Y. Bai, L. Yang, B. Yang, H. Wang, and Z. Wang
A Single Decoy Oligodeoxynucleotides Targeting Multiple Oncoproteins Produces Strong Anticancer Effects
Mol. Pharmacol.,
November 1, 2006;
70(5):
1621 - 1629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Y. Oudit, A. M. Herzenberg, Z. Kassiri, D. Wong, H. Reich, R. Khokha, M. A. Crackower, P. H. Backx, J. M. Penninger, and J. W. Scholey
Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
Am. J. Pathol.,
June 1, 2006;
168(6):
1808 - 1820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. English, Z. Kassiri, I. Koskivirta, S. J. Atkinson, M. Di Grappa, P. D. Soloway, H. Nagase, E. Vuorio, G. Murphy, and R. Khokha
Individual Timp Deficiencies Differentially Impact Pro-MMP-2 Activation
J. Biol. Chem.,
April 14, 2006;
281(15):
10337 - 10346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. Panek and M. Bader
Matrix Reloaded: The Matrix Metalloproteinase Paradox
Hypertension,
April 1, 2006;
47(4):
640 - 641.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Janssens and H. R. Lijnen
What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Cardiovasc Res,
February 15, 2006;
69(3):
585 - 594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Smookler, F. F. Mohammed, Z. Kassiri, G. S. Duncan, T. W. Mak, and R. Khokha
Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation
J. Immunol.,
January 15, 2006;
176(2):
721 - 725.
[Abstract]
[Full Text]
[PDF]
|
|
|
